Japan, Jan. 20 -- EXELIXIS INC has got intellectual property rights for 'CRYSTALLINE FORMS AND SALT FORMS OF KINASE INHIBITOR.' Other related details are as follows:
Application Number: JP,2023-221085
Category (FI): A61P35/02,A61P35/00,A61K31/47,C07D215/48
Stage: Grant (IP right document published.)
Filing Date: Dec. 27, 2023
Publication Date: March 19, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
